perillyl alcohol
Sponsors
National Cancer Institute (NCI), University of Wisconsin, Madison, Indiana University School of Medicine, The Cleveland Clinic, University of Arizona
Conditions
Breast CancerGlioblastoma MultiformeLymphomaPancreatic CancerPrecancerous ConditionProstate CancerUnspecified Adult Solid Tumor, Protocol Specific
Phase 1
Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy
NCT00022425
Start: 2001-06-30Updated: 2013-12-18
Perillyl Alcohol in Treating Patients With Refractory Cancer
CompletedNCT00002862
Start: 1996-10-31Updated: 2013-02-11
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
Active, not recruitingNCT02704858
Start: 2017-08-01End: 2026-12-01Target: 49Updated: 2026-09-14
Phase 2
Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer
CompletedNCT00003769
Start: 1999-02-28End: 2001-07-31Updated: 2014-09-10
Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
CompletedNCT00003219
Start: 1998-05-31End: 1998-05-31Updated: 2019-12-13
Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
CompletedNCT00003238
Start: 1998-02-28Updated: 2019-12-13
Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses
CompletedNCT00608634
Start: 2004-05-31End: 2009-06-30Updated: 2015-04-01